Live update #11

Rocket Lab’s Q3 Earnings Call Tonight Could Reveal What’s Next for Neutron

RKLB
Rocket Lab

Call preview · Q3 2026


Mon, Nov 9
Earnings call · after close

Neutron has come up on every call for the past year, and with first launch now pushed to no earlier than 2027, the 5pm ET call is where analysts will press for a credible date. The margin thread matters just as much after non-GAAP gross margin slipped to 38.4% from 41.9% a year ago, which tests the bull case we laid out at 4:10pm that cadence closes the loss gap before Neutron flies.

Analyst hot topics · last 4 calls
Q4 25Q1 26Q2 26Q3 26
  • Neutron development & launch cadence
  • Space Systems awards & backlog
  • Vertical integration & M&A strategy
  • National security & defense programs
  • Margin profile & revenue recognition
  • Electron & HASTE launch cadence

Contact [email protected] for any questions or corrections.

More From This Coverage

Newest first
Thomas Richmond

That wraps up our initial coverage of Rocket Lab’s Q3 results. Thank you for stopping by!

Thomas Richmond
RKLB
Rocket Lab

Q3 2026

4:06pm ET

EPS
-$0.12
est -$0.07
-80.5%

Revenue
$268M
est $257M
+4.1%

Backlog jumped 52% in a single quarter to a record $3.57 billion, built on roughly $1 billion of new launch contracts signed in Q3. Revenue beat expectations while the GAAP loss missed expectations on debt extinguishment and Iridium deal costs. Q4 revenue guidance of $270 million to $290 million keeps the growth curve intact.

Thomas Richmond
RKLB
Rocket Lab

Thesis check

4:10pm ET

intact$58.86 +10.9% today
“Rocket Lab's launch cadence scales revenue fast enough to close the loss gap before Neutron flies”

Bull case
  • Q3 revenue of $267.83 million beat the $257.18 million consensus, up 73% year over year and 14% from Q2
  • revenue landed above the top of management's $250 million to $265 million guidance range
  • operating margin had already narrowed to -24.6% in Q2 2026 from -49.5% two years earlier
  • shares up double digits on the report despite prediction markets pricing only a 37% chance of a beat
Bear case
  • EPS of -$0.12 missed the -$0.07 estimate, with losses widening as revenue climbs
  • Q2 2026 gross margin slipped to 36.1% from 38.2% in Q1, the first step back in two years
  • Neutron pad delivery target sits in Q4 2026 with no revenue from the larger vehicle yet
  • stock still 25% below its 200-day average going into the report

The 73% revenue jump tips it: cadence is scaling faster than Wall Street modeled, and investors appear willing to fund the losses while that holds. The wider EPS miss is the crack to watch. A second straight quarter of falling gross margin, or any slip in the Q4 Neutron pad timeline, would turn this to weakening.

Thomas Richmond

Rocket Lab just reported Q3 2026 earnings, with shares initially up 1% following the report. Revenue topped expectations, although losses were significantly wider than Wall Street anticipated.

  • Revenue: $267.83 million vs. $257.18 million expected 🟢
  • EPS: -$0.12 vs. -$0.07 expected 🔴

Quick Read:

  • Revenue beat expectations by 4%, climbing 73% year over year and 14% quarter over quarter.
  • Losses widened significantly, with EPS missing estimates by roughly 71%, raising questions about profitability as Rocket Lab continues investing in its expansion.
  • Investors will now be watching for management’s latest updates on the Neutron rocket program and its development timeline.
Thomas Richmond
RKLB
Rocket Lab

Margin story · Q3 2024 – Q2 2026

3:15pm ET

Gross
36.1%+4.0pp YoY
Operating
-24.6%+16.7pp YoY
Net
-21.0%+25.0pp YoY

Rocket Lab's gross margin has climbed from 26.7% in Q3 2024 to the mid-30s, but it slipped to 36.1% in Q2 2026 from 38.2% in Q1, the first step back in two years. Operating margin keeps narrowing (-24.6% in Q2 2026 versus -49.5% two years ago), so tonight's question is whether Neutron spending stalls that progress or the launch mix pushes gross margin back above 38%.

Operating margin by quarter

-22.6%-37.0%-51.5%

Thomas Richmond
RKLB
Rocket Lab

Technical setup

3:05pm ET

Support & resistance · chart through Mon, Nov 9
  • R2$86.19+46.0%
  • R1$61.13+3.5%
  • Now$59.05
  • S1$49.25-16.6%
50-day avg
$62.45-5.4% below
200-day avg
$78.72-25.0% below
52-week range
$37.57 – $151.00

Rocket Lab goes into tonight's report at $59.05, pinned below both its 50-day average of $62.45 and the $61.13 resistance shelf, with the 200-day way up at $78.72. Resistance at $61.13 is the level that matters: reclaiming it is the first step toward repairing a chart that sits less than half of the $151 52-week high. Missing expectations puts $49.25 support back in play.

Thomas Richmond
RKLB
Rocket Lab

Prediction markets

3:00pm ET

Will Rocket Lab (RKLB) beat quarterly earnings?
37%Yes
Polymarket · $4k traded · resolves Mon, Nov 9

Market participants are leaning against an earnings beat tonight, assigning well under a 50% probability that Rocket Lab clears the GAAP EPS line. That skepticism sits awkwardly next to a $35.2 billion market cap and the Neutron pad timeline investors flagged this morning, so any surprise on the bottom line cuts against where the crowd is positioned.

Thomas Richmond
RKLB
Rocket Lab

Options positioning

2:55pm ET

Put/call 0.45Calls dominant
CallsPuts

ATM implied vol
132.2%
Expiry
Fri, Nov 13chain as of Fri, Nov 6

A 0.45 put/call ratio into tonight's report means calls outnumber puts better than two to one, with the heaviest open interest stacked at the $55 strike just above the $54 at-the-money line. That positioning shows traders leaning hard toward an upside Neutron update, and the one-sided call crowding leaves little cushion if the news disappoints. At-the-money implied volatility of 132.2% on the Nov. 13 expiration shows how violent the reaction is expected to be either way.

Open interest near the money · puts / calls
  • $51

    396 / 1.2k

  • $52

    1.8k / 739

  • $53

    465 / 912

  • $54

    649 / 536

  • $55

    1.1k / 2k

  • $56

    252 / 657

Thomas Richmond
RKLB
Rocket Lab

Last quarter — Q2 2026

2:50pm ET

EPS
-$0.08vs -$0.08 est -4.3%
Revenue
$234Mvs $231M est +1.4%
Earnings-day move +0.0%Since report -26.5%

Q2 showed Rocket Lab can keep revenue climbing on launch cadence while the bottom line stays in the red, and tonight's numbers land with expectations already reset since that August report. With the Neutron pad delivery target we flagged this afternoon now inside the next quarter, the Q3 update matters more for the schedule than for the revenue line.

Price since the report

$85$64$43

Reported Mon, Aug 10 · next print Mon, Nov 9

Thomas Richmond
RKLB
Rocket Lab

Tracked 13F positioning

3:10pm ET

$300Macross 8 tracked filers
4 added · 3 trimmed · 2 new · 2 exited

  • ARK Investment Management LLC

    $166M-0.3%

  • D. E. Shaw & Co Inc

    $112M-0.7%

  • Balyasny Asset Management LP

    $7M+5.8%

  • Gotham Asset Management LLC

    $6M+0.1%

  • Renaissance Technologies LLC

    $5MNew

  • Brevan Howard

    $2M—

  • Bridgewater Associates LP

    $1M-0.3%

  • Point72 Asset Management LP

    $1MNew

+ 2 more tracked holders

As of Jun 30, 2026 quarter end · 13F disclosures lag ~45 days — long positions only, tracked filers only.

Among the eight filers disclosing positions, the two biggest holders of Rocket Lab were both trimming as of June 30, with ARK still sitting on roughly $166 million of the stock after cutting its share count. Renaissance Technologies and Point72 opened new positions in the same quarter, so these filers went into tonight's report split four buyers to three trimmers. Note these disclosures are about 45 days stale and predate the Q3 setup entirely.

Thomas Richmond

Rocket Lab reports Q3 earnings tonight, and investors will be watching Neutron above all else.

The company’s Q4 2026 launch pad delivery target is approaching fast, which makes any update on Neutron’s development schedule a potential stock-moving catalyst.

Wall Street expects $257.18 million in revenue, compared with management’s guidance of $250 million to $265 million. However, GAAP gross margins are expected to fall to 29%–31%, down from 36.1% last quarter.

The big question tonight: Can management reassure investors that Neutron remains on schedule, or will another potential delay raise concerns about cash burn and future dilution?

View the full live blog (12 updates) →